# Tetra Tech Inc: financial statements, quarterly

TTEK · Nasdaq · CIK 831641 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 27

Pages: [Overview](/companies/ttek.md) · [Financials](/companies/ttek/financials.md) · [Filings](/companies/ttek/filings.md) · [Insiders](/companies/ttek/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttek/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,261](/filings/0000831641-24-000063.md) | [1,228](/filings/0000831641-25-000032.md) | [1,252](/filings/0000831641-25-000032.md) | [1,344](/filings/0000831641-25-000032.md) | [1,374](/filings/0000831641-25-000032.md) | [1,421](/filings/0000831641-26-000005.md) | [1,322](/filings/0000831641-26-000011.md) | [1,370](/filings/0000831641-26-000017.md) | [1,330](/filings/0000831641-25-000032.md) | [1,211](/filings/0000831641-26-000005.md) | [1,220](/filings/0000831641-26-000011.md) | [1,309](/filings/0000831641-26-000017.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | [223](/filings/0000831641-26-000005.md) | [218](/filings/0000831641-26-000011.md) | [217](/filings/0000831641-26-000017.md) | [167 d](/filings/0000831641-25-000032.md) | [173](/filings/0000831641-26-000005.md) | [171](/filings/0000831641-26-000011.md) | [200](/filings/0000831641-26-000017.md) |
| Gross profit | $m | [212 d](/filings/0000831641-25-000032.md) | [190](/filings/0000831641-25-000005.md) | [207](/filings/0000831641-25-000019.md) | [223](/filings/0000831641-25-000023.md) | [245 d](/filings/0000831641-25-000032.md) | [221](/filings/0000831641-26-000005.md) | [214](/filings/0000831641-26-000011.md) | [252](/filings/0000831641-26-000017.md) | [274 d](/filings/0000831641-25-000032.md) | [220](/filings/0000831641-26-000005.md) | [214](/filings/0000831641-26-000011.md) | [243](/filings/0000831641-26-000017.md) |
| Operating income | $m | [107](/filings/0000831641-24-000063.md) | [111](/filings/0000831641-25-000032.md) | [118](/filings/0000831641-25-000032.md) | [129](/filings/0000831641-25-000032.md) | [143](/filings/0000831641-25-000032.md) | [22.5](/filings/0000831641-26-000005.md) | [39.6](/filings/0000831641-26-000011.md) | [165](/filings/0000831641-26-000017.md) | [181](/filings/0000831641-25-000032.md) | [141](/filings/0000831641-26-000005.md) | [132](/filings/0000831641-26-000011.md) | [158](/filings/0000831641-26-000017.md) |
| Interest expense | $m | not reported | [9.6](/filings/0000831641-25-000005.md) | [9.9](/filings/0000831641-25-000019.md) | [9.9](/filings/0000831641-25-000023.md) | [15.2 d](/filings/0000831641-25-000032.md) | [7.2](/filings/0000831641-26-000005.md) | [8.5](/filings/0000831641-26-000011.md) | [8.3](/filings/0000831641-26-000017.md) | [16.6 d](/filings/0000831641-25-000032.md) | [7.1](/filings/0000831641-26-000005.md) | [8.8](/filings/0000831641-26-000011.md) | [7.2](/filings/0000831641-26-000017.md) |
| Income tax | $m | [40.7 d](/filings/0000831641-25-000032.md) | [26.5](/filings/0000831641-25-000005.md) | [31.3](/filings/0000831641-25-000019.md) | [32.9](/filings/0000831641-25-000023.md) | [39.3 d](/filings/0000831641-25-000032.md) | [14.5](/filings/0000831641-26-000005.md) | [25.7](/filings/0000831641-26-000011.md) | [42.8](/filings/0000831641-26-000017.md) | [46.6 d](/filings/0000831641-25-000032.md) | [36.4](/filings/0000831641-26-000005.md) | [33.5](/filings/0000831641-26-000011.md) | [41.0](/filings/0000831641-26-000017.md) |
| Net income | $m | [53.6](/filings/0000831641-24-000063.md) | [75.0](/filings/0000831641-25-000005.md) | [76.4](/filings/0000831641-25-000019.md) | [85.8](/filings/0000831641-25-000023.md) | [96.2](/filings/0000831641-25-000032.md) | [0.8](/filings/0000831641-26-000005.md) | [5.4](/filings/0000831641-25-000019.md) | [114](/filings/0000831641-25-000023.md) | [128](/filings/0000831641-25-000032.md) | [105](/filings/0000831641-26-000005.md) | [93.8](/filings/0000831641-26-000011.md) | [110](/filings/0000831641-26-000017.md) |
| Diluted EPS | $ per share | [0.20](/filings/0000831641-24-000063.md) | [0.28](/filings/0000831641-25-000032.md) | [0.28](/filings/0000831641-25-000032.md) | [0.32](/filings/0000831641-25-000032.md) | [0.35](/filings/0000831641-25-000032.md) | [0.00](/filings/0000831641-26-000005.md) | [0.02](/filings/0000831641-26-000011.md) | [0.43](/filings/0000831641-26-000017.md) | [0.48](/filings/0000831641-25-000032.md) | [0.40](/filings/0000831641-26-000005.md) | [0.36](/filings/0000831641-26-000011.md) | [0.42](/filings/0000831641-26-000017.md) |
| Basic EPS | $ per share | [0.20](/filings/0000831641-24-000063.md) | [0.28](/filings/0000831641-25-000032.md) | [0.29](/filings/0000831641-25-000032.md) | [0.32](/filings/0000831641-25-000032.md) | [0.36](/filings/0000831641-25-000032.md) | [0.00](/filings/0000831641-26-000005.md) | [0.02](/filings/0000831641-26-000011.md) | [0.43](/filings/0000831641-26-000017.md) | [0.49](/filings/0000831641-25-000032.md) | [0.40](/filings/0000831641-26-000005.md) | [0.36](/filings/0000831641-26-000011.md) | [0.42](/filings/0000831641-26-000017.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [169](/filings/0000831641-24-000063.md) | [199](/filings/0000831641-24-000008.md) | [210](/filings/0000831641-24-000029.md) | [212](/filings/0000831641-24-000035.md) | [233](/filings/0000831641-26-000017.md) | [248](/filings/0000831641-25-000005.md) | [179](/filings/0000831641-25-000019.md) | [243](/filings/0000831641-25-000023.md) | [167](/filings/0000831641-26-000017.md) | [269](/filings/0000831641-26-000005.md) | [224](/filings/0000831641-26-000011.md) | [231](/filings/0000831641-26-000017.md) |
| Current assets | $m | [1,356](/filings/0000831641-24-000063.md) | [1,454](/filings/0000831641-24-000008.md) | [1,480](/filings/0000831641-24-000029.md) | [1,506](/filings/0000831641-24-000035.md) | [1,527](/filings/0000831641-25-000032.md) | [1,632](/filings/0000831641-25-000005.md) | [1,666](/filings/0000831641-25-000019.md) | [1,620](/filings/0000831641-25-000023.md) | [1,621](/filings/0000831641-26-000017.md) | [1,604](/filings/0000831641-26-000005.md) | [1,542](/filings/0000831641-26-000011.md) | [1,580](/filings/0000831641-26-000017.md) |
| Total assets | $m | [3,820](/filings/0000831641-24-000063.md) | [3,951](/filings/0000831641-24-000008.md) | [4,071](/filings/0000831641-24-000029.md) | [4,085](/filings/0000831641-24-000035.md) | [4,193](/filings/0000831641-25-000032.md) | [4,179](/filings/0000831641-25-000005.md) | [4,184](/filings/0000831641-25-000019.md) | [4,353](/filings/0000831641-25-000023.md) | [4,282](/filings/0000831641-26-000017.md) | [4,265](/filings/0000831641-26-000005.md) | [4,362](/filings/0000831641-26-000011.md) | [4,388](/filings/0000831641-26-000017.md) |
| Current liabilities | $m | [1,208](/filings/0000831641-24-000063.md) | [1,161](/filings/0000831641-24-000008.md) | [1,194](/filings/0000831641-24-000029.md) | [1,246](/filings/0000831641-24-000035.md) | [1,220](/filings/0000831641-25-000032.md) | [1,267](/filings/0000831641-25-000005.md) | [1,517](/filings/0000831641-25-000019.md) | [1,376](/filings/0000831641-25-000023.md) | [1,379](/filings/0000831641-26-000017.md) | [1,221](/filings/0000831641-26-000005.md) | [1,229](/filings/0000831641-26-000011.md) | [1,334](/filings/0000831641-26-000017.md) |
| Long-term debt | $m | [880](/filings/0000831641-24-000035.md) | [945](/filings/0000831641-24-000008.md) | [951](/filings/0000831641-24-000029.md) | [862](/filings/0000831641-24-000035.md) | [813](/filings/0000831641-25-000032.md) | [888](/filings/0000831641-25-000005.md) | [764](/filings/0000831641-25-000019.md) | [862](/filings/0000831641-25-000023.md) | [763](/filings/0000831641-26-000017.md) | [834](/filings/0000831641-26-000005.md) | [880](/filings/0000831641-26-000011.md) | [801](/filings/0000831641-26-000017.md) |
| Current portion of debt | $m | [0.0](/filings/0000831641-23-000082.md) | not reported | not reported | not reported | [0.0](/filings/0000831641-25-000019.md) | not reported | [250](/filings/0000831641-25-000019.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,403](/filings/0000831641-24-000063.md) | [1,538](/filings/0000831641-24-000008.md) | [1,585](/filings/0000831641-24-000029.md) | [1,666](/filings/0000831641-24-000035.md) | [1,830](/filings/0000831641-25-000032.md) | [1,692](/filings/0000831641-25-000005.md) | [1,574](/filings/0000831641-25-000019.md) | [1,742](/filings/0000831641-25-000023.md) | [1,780](/filings/0000831641-26-000017.md) | [1,846](/filings/0000831641-26-000005.md) | [1,863](/filings/0000831641-26-000011.md) | [1,852](/filings/0000831641-26-000017.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0000831641-25-000032.md) | [9.2](/filings/0000831641-25-000005.md) | [103 d](/filings/0000831641-25-000019.md) | [141 d](/filings/0000831641-25-000023.md) | [106 d](/filings/0000831641-25-000032.md) | [13.1](/filings/0000831641-26-000005.md) | [(5.8) d](/filings/0000831641-26-000011.md) | [350 d](/filings/0000831641-26-000017.md) | [101 d](/filings/0000831641-25-000032.md) | [72.3](/filings/0000831641-26-000005.md) | [165 d](/filings/0000831641-26-000011.md) | [229 d](/filings/0000831641-26-000017.md) |
| Capital expenditure | $m | [9.6 d](/filings/0000831641-25-000032.md) | [3.4](/filings/0000831641-25-000005.md) | [4.0 d](/filings/0000831641-25-000019.md) | [3.9 d](/filings/0000831641-25-000023.md) | [6.8 d](/filings/0000831641-25-000032.md) | [3.4](/filings/0000831641-26-000005.md) | [5.6 d](/filings/0000831641-26-000011.md) | [3.5 d](/filings/0000831641-26-000017.md) | [6.1 d](/filings/0000831641-25-000032.md) | [4.2](/filings/0000831641-26-000005.md) | [6.0 d](/filings/0000831641-26-000011.md) | [3.8 d](/filings/0000831641-26-000017.md) |
| Dividends paid | $m | [13.8 d](/filings/0000831641-25-000032.md) | [13.9](/filings/0000831641-25-000005.md) | [13.9 d](/filings/0000831641-25-000019.md) | [15.5 d](/filings/0000831641-25-000023.md) | [15.5 d](/filings/0000831641-25-000032.md) | [15.5](/filings/0000831641-26-000005.md) | [15.4 d](/filings/0000831641-26-000011.md) | [17.1 d](/filings/0000831641-26-000017.md) | [17.0 d](/filings/0000831641-25-000032.md) | [16.9](/filings/0000831641-26-000005.md) | [16.9 d](/filings/0000831641-26-000011.md) | [18.6 d](/filings/0000831641-26-000017.md) |
| Share repurchases | $m | [0.0 d](/filings/0000831641-25-000032.md) | [0.0](/filings/0000831641-25-000005.md) | [0.0 d](/filings/0000831641-25-000019.md) | [0.0 d](/filings/0000831641-25-000023.md) | [0.0 d](/filings/0000831641-25-000032.md) | [25.0](/filings/0000831641-26-000005.md) | [150 d](/filings/0000831641-26-000011.md) | [25.0 d](/filings/0000831641-26-000017.md) | [50.0 d](/filings/0000831641-25-000032.md) | [50.0](/filings/0000831641-26-000005.md) | [52.0 d](/filings/0000831641-26-000011.md) | [100 d](/filings/0000831641-26-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2023 (2023-10-01) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [269](/filings/0000831641-24-000063.md) | [269](/filings/0000831641-25-000032.md) | [269](/filings/0000831641-25-000032.md) | [270](/filings/0000831641-25-000032.md) | [272](/filings/0000831641-25-000032.md) | [272](/filings/0000831641-26-000005.md) | [267](/filings/0000831641-26-000011.md) | [265](/filings/0000831641-26-000017.md) | [264](/filings/0000831641-25-000032.md) | [263](/filings/0000831641-26-000005.md) | [262](/filings/0000831641-26-000011.md) | [260](/filings/0000831641-26-000017.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 256,044,428 at 2026-07-20, from the cover of the [10-Q filed 2026-07-31](/filings/0000831641-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.